These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34008780)

  • 1. Adverse events following immunization in pregnant women from Minas Gerais.
    Silveira IOD; Silva TPRD; Luvisaro BMO; Silva RBD; Gusmão JD; Vimieiro AM; Oliveira VC; Souza KCR; Faria APV; Matozinhos FP
    Rev Saude Publica; 2021; 55():24. PubMed ID: 34008780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of immunization errors in pregnant women.
    da Silva TPR; da Silva SF; Dutra MM; da Silva RB; Gusmão JD; Matozinhos FP
    Rev Esc Enferm USP; 2021; 55():e20200544. PubMed ID: 34605531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse events following immunization against SARS-CoV-2 (covid-19) in the state of Minas Gerais.
    Silva RBD; Silva TPRD; Sato APS; Lana FCF; Gusmão JD; Souza JFA; Matozinhos FP
    Rev Saude Publica; 2021; 55():66. PubMed ID: 34706042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of adverse events following immunization in Minas Gerais, Brazil, 2011: a cross-sectional study.
    Silva SS; Oliveira VC; Ribeiro HC; Alves TG; Cavalcante RB; Guimarães EA
    Epidemiol Serv Saude; 2016; 25(1):45-54. PubMed ID: 27861677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse event following immunization or vaccination in children in Minas Gerais: 2015 to 2020.
    Camargos SM; Oliveira MLS; Luvisaro BMO; Silva TPRD; Souza JFA; Vimieiro AM; Silva TMRD; Matozinhos FP
    Rev Bras Epidemiol; 2023; 26():e230056. PubMed ID: 38088715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of immunization errors in the state of Minas Gerais, Brazil: a cross-sectional study, 2015-2019.
    Donnini DA; Silva CMB; Gusmão JD; Matozinhos FP; Silva RB; Amaral GG; Guimarães EAA; Oliveira VC
    Epidemiol Serv Saude; 2022; 31(3):e2022055. PubMed ID: 36351058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse event following vaccine surveillance in Kaduna State, Northwestern Nigeria (January 2018 -June 2019): analysis of health facility´s records.
    Ishaku SG; Umeh G; Adzu B; Onimisi A; Dauda M; Iyal HA; Iliyasu N; Sunday DJ; Daikwo J; Yates SM; Ibrahim II; Samaila LH; Abdullahi B; Parom SK; Maiwashi KY; Zakari F; Nuhu KS
    Pan Afr Med J; 2021; 40():268. PubMed ID: 35251462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A global survey of adverse event following immunization surveillance systems for pregnant women and their infants.
    Cassidy C; MacDonald NE; Steenbeek A; Ortiz JR; Zuber PL; Top KA
    Hum Vaccin Immunother; 2016 Aug; 12(8):2010-2016. PubMed ID: 27159639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adequacy assessment of immunobiological agent conservation in the Western Health macro-region of Minas Gerais State, Brazil: a descriptive study, 2017.
    Amaral GG; Guimarães EAA; Tavares LOM; Silva BS; Cortez DN; Oliveira VC
    Epidemiol Serv Saude; 2021; 30(3):e20201017. PubMed ID: 34431956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse event following immunization surveillance systems for pregnant women and their infants: a systematic review.
    Cassidy C; MacDonald NE; Steenbeek A; Top KA
    Pharmacoepidemiol Drug Saf; 2015 Apr; 24(4):361-7. PubMed ID: 25683692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deaths reported to national surveillance for adverse events following immunization in China, 2010-2015.
    Wu W; Liu D; Nuorti JP; Li K; Xu D; Ye J; Zheng J; Cao L; Wang H
    Vaccine; 2019 Feb; 37(9):1182-1187. PubMed ID: 30709723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse events following immunization: Findings from 2017/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017/2018 measles vaccination campaign.
    Gbenewei E; Nomhwange T; Taiwo L; Ayodeji I; Yusuf K; Jean Baptiste AE; Nsubuga P; Braka F; Oteri J; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C82-C88. PubMed ID: 33714655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.
    Clothier HJ; Crawford NW; Russell M; Kelly H; Buttery JP
    Drug Saf; 2017 Jun; 40(6):483-495. PubMed ID: 28342074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of adverse events following immunization in Zhejiang, China, 2019: a retrospective cross-sectional study based on the passive surveillance system.
    Pan X; Lv H; Chen F; Wang Y; Liang H; Shen L; Chen Y; Hu Y
    Hum Vaccin Immunother; 2021 Oct; 17(10):3823-3830. PubMed ID: 34170800
    [No Abstract]   [Full Text] [Related]  

  • 15. [Surveillance of adverse events following immunization in Minhang district of Shanghai from 2007 to 2010].
    Zhang LP; Yu F; Jin BF; Wang Y; Xu HL; DU Y
    Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):859-64. PubMed ID: 23302620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance for adverse events following immunization from 2008 to 2011 in Zhejiang Province, China.
    Hu Y; Li Q; Lin L; Chen E; Chen Y; Qi X
    Clin Vaccine Immunol; 2013 Feb; 20(2):211-7. PubMed ID: 23239804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active SMS-based surveillance of adverse events following immunisation with influenza and pertussis-containing vaccines in Australian pregnant women using AusVaxSafety.
    Glover C; Crawford N; Leeb A; Wood N; Macartney K
    Vaccine; 2020 Jun; 38(31):4892-4900. PubMed ID: 32499067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying adverse events of vaccines using a Bayesian method of medically guided information sharing.
    Crooks CJ; Prieto-Merino D; Evans SJ
    Drug Saf; 2012 Jan; 35(1):61-78. PubMed ID: 22136183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A scoping review of active, participant-centred, digital adverse events following immunization (AEFI) surveillance: A Canadian immunization research network study.
    Psihogios A; Brianne Bota A; Mithani SS; Greyson D; Zhu DT; Fung SG; Wilson SE; Fell DB; Top KA; Bettinger JA; Wilson K
    Vaccine; 2022 Jul; 40(31):4065-4080. PubMed ID: 35680501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.
    LaRussa PS; Edwards KM; Dekker CL; Klein NP; Halsey NA; Marchant C; Baxter R; Engler RJ; Kissner J; Slade BA
    Pediatrics; 2011 May; 127 Suppl 1():S65-73. PubMed ID: 21502239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.